The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Lovaza

Amarin's AMR101 Offers Catalysts Beyond FDA Approval -

A blockbuster market place ripe for new treatments. The drug will compete head on with Glaxo's (GSK) Lovaza, which raked in nearly a billion in U.S. sales last year. The two drugs will jockey for position in treating those with very high triglyceride ...

Amarin fish-oil drug approved for sale in US - MSN Money

Some analysts believe Amarin's drug will eventually be a blockbuster product that takes sales from GlaxoSmithKline's (GSK) Lovaza. A recent survey by Leerink Swann found a number of doctors who said they were enthusiastic about prescribing Amarin's pill.

Roth Capital Says Amarin's Approval Provides Visibility for Neptune reiterates Buy rating and $10.30 price target - Reuters

The visibility on what transpires with Amarin should positively affect Neptune, in our belief, based on our continuing thesis that NKOR (Neptune Krill Oil) and CaPreR (pharmaceutical grade) > Vascepa > Lovaza with regard to potential clinical benefit.

'Wild' Week Will Be Followed by a 'Crazy' Week for Amarin (AMRN) -

That said, we continue to expect an FDA approval on or before the July 26 PDUFA date." LeCroy said there are a few significant differences exist between Lovaza and mock-Vascepa PIs - "The Vascepa PI discusses triglycerides, apolipoprotein B (apoB ...

Are You a Vitamin Junkie? - Cape May County Herald

They are subjected to clinical trials, are patented and are only available by prescription. Three examples are Lovaza (fish oil), Deplan (folic acid), and Cerefolin (B vitamin complex). The company that makes the latter two actually has drug ...

FDA Okays Amarin's Vascepa To Reduce Triglyceride Levels - Quick Facts - NASDAQ

This is Amarin's first drug that has passed muster with the FDA. Vascepa will now compete with GlaxoSmithKline Plc's (GSK, GSK.L) Lovaza. "FDA approval of Vascepa represents the introduction of an important new treatment option for patients with ...

Amarin shares jump after website goof on heart drug approval - Reuters India

Regulatory approval will allow the company to take on GlaxoSmithKline Plc's (GSK.L) popular heart pill Lovaza. Both drugs contain omega-3 fatty acids, the heart-protecting chemicals found in fish oil, and are designed to treat patients with very ...

Amarin: Prepping for FDA Approval Decision - Inside Fidelity

Here's the simplest way of thinking about Vascepa's commercial potential: Glaxo's Lovaza generates sales of around $1 billion annually derived from single-digit market share among the 3.8 million people with very high trigylceride levels. Lovaza is not ...

Blogspot logo    Latest Posts from Marc Faber blog
Blogspot logo    Latest Posts from Henrique Simoes blog
  Latest Posts from Mad Money 
Cramer?s Exec Cut: How IBM, PPG and Splunk are powering daily life
Cramer Remix: My advice for Lloyd Blankfein
Cramer's lightning round: Buy Cisco before its quarterly earnings report
WWE is a 'data powerhouse' thanks to content, growth and digital, CFO says
Cramer: This move by Amazon is a clarion call to buy the stock
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\\httpdocs\ on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\\httpdocs\products-on-the-news.php on line 437
Blogspot logo    Latest Posts from Random Roger
Bitcoin Hedge Fund Proliferation
Chip Off The Old Block?Chain
The Bond Bear Has Started?Again!
Maven Recap
Can The S&P 500 Really Go To 3700?

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis



                 Copyright Leaderglobe.